{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:51:59Z","timestamp":1792050719676,"version":"4.4.0"},"reference-count":68,"publisher":"American Association for Cancer Research (AACR)","issue":"20","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403438"],"award-info":[{"award-number":["82403438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203033"],"award-info":[{"award-number":["82203033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32401087"],"award-info":[{"award-number":["32401087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303723"],"award-info":[{"award-number":["82303723"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023YFS0166"],"award-info":[{"award-number":["2023YFS0166"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC1914"],"award-info":[{"award-number":["2026NSFSC1914"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023YFS0001"],"award-info":[{"award-number":["2023YFS0001"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1930"],"award-info":[{"award-number":["2024NSFSC1930"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC1917"],"award-info":[{"award-number":["2026NSFSC1917"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","award":["Z2023JC002"],"award-info":[{"award-number":["Z2023JC002"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["2024-YF05-00597-SN"],"award-info":[{"award-number":["2024-YF05-00597-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Neoadjuvant immunochemotherapy (nICT) has emerged as a promising neoadjuvant strategy for esophageal squamous cell carcinoma (ESCC). Identification of the factors affecting responsiveness to nICT could help further improve treatment efficacy. In this study, we performed single-cell analysis on 14 patients with ESCC undergoing nICT and revealed tumor microenvironment (TME) features associated with differential treatment responses. Nonnegative matrix factorization (NMF) identified five coordinated cellular programs with distinct response associations. Specifically, the NMF3 program, mainly comprising immunosuppressive cell subsets, was enriched in the minimal or no pathologic tumor regression [tumor regression staging 3 (TRS3)] group, in which regulatory T cells (Treg) and dendritic cells (DC) exhibited a close correlation. In addition, elevated expression of mitochondrial transcription factor A (TFAM) in DCs was associated with increased Treg infiltration in the TRS3 group. A myeloid-specific Tfam knockout mouse model showed that TFAM deficiency reversed the immunosuppressive TME, inhibited tumor growth, and enhanced the response to anti\u2013programmed cell death protein 1 therapy in ESCC. Mechanistically, TFAM deficiency in DCs activated the stimulator of IFN genes (STING)\u2013TBK1\u2013IRF3 pathway, thereby promoting DC maturation to enhance antitumor immunity. Overall, this study characterized the TME in residual ESCC after nICT and revealed an association between elevated TFAM expression in DCs and poor responsiveness to nICT. These findings indicate the critical role of TFAM deficiency in DCs in activating antitumor immunity, highlighting the potential of targeting TFAM to improve the efficacy of immunotherapy and optimize therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>TFAM mediates dendritic cell activation through the STING-TBK1-IRF3 pathway and is associated with responsiveness to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma, identifying TFAM as a putative immunotherapeutic target and biomarker.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-25-4738","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:45:59Z","timestamp":1784573159000},"page":"5287-5306","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-Cell Analysis of Residual Esophageal Squamous Cell Carcinoma after Neoadjuvant Immunochemotherapy Reveals TFAM-Mediated Immunoregulation in Dendritic Cells"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0888-247X","authenticated-orcid":false,"given":"Linyan","family":"Chen","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 1 Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6346-8810","authenticated-orcid":false,"given":"Tang","family":"Feng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 2 Department of Biotherapy, Cancer Center, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9620-2066","authenticated-orcid":false,"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 3 Department of Thoracic Surgery, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-3019","authenticated-orcid":false,"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 1 Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0702-7384","authenticated-orcid":false,"given":"Yutian","family":"Lai","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 4 Department of Lung Cancer, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7819-4304","authenticated-orcid":false,"given":"Xiafei","family":"Gu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 5 Department of Pathology, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-2195","authenticated-orcid":false,"given":"Tianqi","family":"Lu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00ebdgr24","id-type":"ROR","asserted-by":"publisher"}],"name":"The Third People\u2019s Hospital of Chengdu 6 Obesity and Metabolism Medicine-Engineering Integration Laboratory, Department of General Surgery, , China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2936-8114","authenticated-orcid":false,"given":"Pingxin","family":"Han","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 7 West China School of Clinical Medicine, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2578-6789","authenticated-orcid":false,"given":"Ting","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 2 Department of Biotherapy, Cancer Center, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-8720","authenticated-orcid":false,"given":"Wenjun","family":"Meng","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 8 Department of Pain Management, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9660-9002","authenticated-orcid":false,"given":"Zijian","family":"Lu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 5 Department of Pathology, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9258-8510","authenticated-orcid":false,"given":"Jiumei","family":"Wu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 3 Department of Thoracic Surgery, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-2527","authenticated-orcid":false,"given":"Yushang","family":"Yang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 3 Department of Thoracic Surgery, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-1965","authenticated-orcid":false,"given":"Yong","family":"Yuan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 3 Department of Thoracic Surgery, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-8844","authenticated-orcid":false,"given":"Zhenyu","family":"Ding","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 2 Department of Biotherapy, Cancer Center, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9468-0390","authenticated-orcid":false,"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 2 Department of Biotherapy, Cancer Center, West China Hospital, , Chengdu, China."},{"id":[{"id":"https:\/\/ror.org\/011ashp19","id-type":"ROR","asserted-by":"publisher"}],"name":"Sichuan University 9 Department of Biotherapy, Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, , Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2026101503093693800_bib1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026101503093693800_bib2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","article-title":"Epidemiology of esophageal squamous cell carcinoma","volume":"154","author":"Abnet","year":"2018","journal-title":"Gastroenterology"},{"key":"2026101503093693800_bib3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","article-title":"Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials","volume":"32","author":"Oppedijk","year":"2014","journal-title":"J Clin Oncol"},{"key":"2026101503093693800_bib4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/nyas.14508","article-title":"Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma","volume":"1482","author":"Leng","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"2026101503093693800_bib5","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"2026101503093693800_bib6","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial","volume":"36","author":"Yang","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026101503093693800_bib7","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1200\/JCO.2013.53.6532","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901","volume":"32","author":"Mariette","year":"2014","journal-title":"J Clin Oncol"},{"key":"2026101503093693800_bib8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ijc.31312","article-title":"Neoadjuvant treatments for locally advanced, resectable esophageal cancer: a network meta-analysis","volume":"143","author":"Chan","year":"2018","journal-title":"Int J Cancer"},{"key":"2026101503093693800_bib9","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026101503093693800_bib10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejca.2020.08.002","article-title":"Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010","volume":"138","author":"Liu","year":"2020","journal-title":"Eur J Cancer"},{"key":"2026101503093693800_bib11","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.3748\/wjg.v29.i34.5020","article-title":"Perioperative immunotherapy for esophageal squamous cell carcinoma: now and future","volume":"29","author":"Liu","year":"2023","journal-title":"World J Gastroenterol"},{"key":"2026101503093693800_bib12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12916-016-0623-5","article-title":"Cancer immunotherapy: the beginning of the end of cancer?","volume":"14","author":"Farkona","year":"2016","journal-title":"BMC Med"},{"key":"2026101503093693800_bib13","doi-asserted-by":"publisher","first-page":"1383456","DOI":"10.3389\/fimmu.2024.1383456","article-title":"Targeting PD-1\/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges","volume":"15","author":"Javed","year":"2024","journal-title":"Front Immunol"},{"key":"2026101503093693800_bib14","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1470-2045(20)30453-8","article-title":"Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial","volume":"21","author":"Provencio","year":"2020","journal-title":"Lancet Oncol"},{"key":"2026101503093693800_bib15","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1200\/JCO.21.01003","article-title":"Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive bladder cancer","volume":"39","author":"Rose","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026101503093693800_bib16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1158\/1078-0432.CCR-24-2436","article-title":"Intestinal subtype as a biomarker of response to neoadjuvant immunochemotherapy in locally advanced gastric adenocarcinoma: insights from a prospective phase II trial","volume":"31","author":"Wang","year":"2025","journal-title":"Clin Cancer Res"},{"key":"2026101503093693800_bib17","doi-asserted-by":"publisher","first-page":"1051841","DOI":"10.3389\/fimmu.2022.1051841","article-title":"Neoadjuvant immunotherapy for resectable esophageal cancer: a review","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"2026101503093693800_bib18","doi-asserted-by":"publisher","first-page":"e2239778","DOI":"10.1001\/jamanetworkopen.2022.39778","article-title":"Evaluation of clinical and safety outcomes of neoadjuvant immunotherapy combined with chemotherapy for patients with resectable esophageal cancer: a systematic review and meta-analysis","volume":"5","author":"Ge","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026101503093693800_bib19","doi-asserted-by":"publisher","first-page":"9676","DOI":"10.1038\/s41467-025-64660-z","article-title":"Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: phase 2 randomized trial (REVO)","volume":"16","author":"Wang","year":"2025","journal-title":"Nat Commun"},{"key":"2026101503093693800_bib20","doi-asserted-by":"publisher","first-page":"848881","DOI":"10.3389\/fimmu.2022.848881","article-title":"Perioperative outcomes of minimally invasive esophagectomy after neoadjuvant immunotherapy for patients with locally advanced esophageal squamous cell carcinoma","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Immunol"},{"key":"2026101503093693800_bib21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.adro.2018.08.018","article-title":"Role of the immunosuppressive microenvironment in immunotherapy","volume":"3","author":"Tormoen","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"2026101503093693800_bib22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","article-title":"Dendritic cells in cancer: the role revisited","volume":"45","author":"Veglia","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"2026101503093693800_bib23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026101503093693800_bib24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s43556-025-00305-3","article-title":"Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy","volume":"6","author":"Lin","year":"2025","journal-title":"Mol Biomed"},{"key":"2026101503093693800_bib25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41423-023-01086-x","article-title":"Mitochondrial DNA-triggered innate immune response: mechanisms and diseases","volume":"20","author":"Hu","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"2026101503093693800_bib26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.bbagrm.2012.03.002","article-title":"Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number","volume":"1819","author":"Campbell","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2026101503093693800_bib27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","article-title":"Mitochondrial DNA stress primes the antiviral innate immune response","volume":"520","author":"West","year":"2015","journal-title":"Nature"},{"key":"2026101503093693800_bib28","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/s41467-024-46763-1","article-title":"Defective mitochondria remodelling in B cells leads to an aged immune response","volume":"15","author":"Iborra-Pernichi","year":"2024","journal-title":"Nat Commun"},{"key":"2026101503093693800_bib29","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer"},{"key":"2026101503093693800_bib30","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"2026101503093693800_bib31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"2026101503093693800_bib32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"2026101503093693800_bib33","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","article-title":"Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer","volume":"42","author":"Chen","year":"2024","journal-title":"Cancer cell"},{"key":"2026101503093693800_bib34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/44565","article-title":"Learning the parts of objects by non-negative matrix factorization","volume":"401","author":"Lee","year":"1999","journal-title":"Nature"},{"key":"2026101503093693800_bib35","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ccell.2023.06.005","article-title":"Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression","volume":"41","author":"Wang","year":"2023","journal-title":"Cancer Cell"},{"key":"2026101503093693800_bib36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"2026101503093693800_bib37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","article-title":"Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours","volume":"618","author":"Gavish","year":"2023","journal-title":"Nature"},{"key":"2026101503093693800_bib38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat Methods"},{"key":"2026101503093693800_bib39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat Methods"},{"key":"2026101503093693800_bib40","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"2026101503093693800_bib41","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2026101503093693800_bib42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lungcan.2018.01.022","article-title":"Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer","volume":"117","author":"Barua","year":"2018","journal-title":"Lung Cancer"},{"key":"2026101503093693800_bib43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/cac2.12066","article-title":"A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy","volume":"40","author":"Huang","year":"2020","journal-title":"Cancer Commun (Lond)"},{"key":"2026101503093693800_bib44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3892\/ol.2018.8733","article-title":"Tumor angiogenesis and anti-angiogenic gene therapy for cancer","volume":"16","author":"Li","year":"2018","journal-title":"Oncol Lett"},{"key":"2026101503093693800_bib45","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"2026101503093693800_bib46","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","article-title":"Classifying cancer-associated fibroblasts\u2014the good, the bad, and the target","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer cell"},{"key":"2026101503093693800_bib47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.coi.2014.12.009","article-title":"Suppression of antigen presentation by IL-10","volume":"34","author":"Mittal","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"2026101503093693800_bib48","doi-asserted-by":"publisher","first-page":"112805","DOI":"10.1016\/j.celrep.2023.112805","article-title":"MEF2A suppresses stress responses that trigger DDX41-dependent IFN production","volume":"42","author":"Smith","year":"2023","journal-title":"Cell Rep"},{"key":"2026101503093693800_bib49","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","article-title":"Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis","volume":"30","author":"Chung","year":"2019","journal-title":"Cell Metab"},{"key":"2026101503093693800_bib50","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41556-024-01419-6","article-title":"TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA","volume":"26","author":"Liu","year":"2024","journal-title":"Nat Cell Biol"},{"key":"2026101503093693800_bib51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/cancers16020318","article-title":"Advancing esophageal cancer treatment: immunotherapy in neoadjuvant and adjuvant settings","volume":"16","author":"Park","year":"2024","journal-title":"Cancers"},{"key":"2026101503093693800_bib52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"2026101503093693800_bib53","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"2026101503093693800_bib54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026101503093693800_bib55","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2026101503093693800_bib56","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.3390\/ijms21124441","article-title":"Innate immune cells and their contribution to T-cell-based immunotherapy","volume":"21","author":"Ginefra","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026101503093693800_bib57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"2026101503093693800_bib58","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat Med"},{"key":"2026101503093693800_bib59","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1073\/pnas.1003428107","article-title":"Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity","volume":"107","author":"Weinberg","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026101503093693800_bib60","doi-asserted-by":"publisher","first-page":"e005430","DOI":"10.1136\/jitc-2022-005430","article-title":"TFAM deficiency in dendritic cells leads to mitochondrial dysfunction and enhanced antitumor immunity through cGAS-STING pathway","volume":"11","author":"Lu","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2026101503093693800_bib61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"2026101503093693800_bib62","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol"},{"key":"2026101503093693800_bib63","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/JLB.3MR0621-616RR","article-title":"Role of IL-6 in dendritic cell functions","volume":"111","author":"Xu","year":"2022","journal-title":"J Leukoc Biol"},{"key":"2026101503093693800_bib64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molimm.2017.12.001","article-title":"STING, DCs and the link between innate and adaptive tumor immunity","volume":"110","author":"Vatner","year":"2019","journal-title":"Mol Immunol"},{"key":"2026101503093693800_bib65","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.4049\/jimmunol.1401869","article-title":"STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells","volume":"193","author":"Klarquist","year":"2014","journal-title":"J Immunol"},{"key":"2026101503093693800_bib66","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1038\/s41388-022-02365-z","article-title":"TFAM downregulation promotes autophagy and ESCC survival through mtDNA stress-mediated STING pathway","volume":"41","author":"Li","year":"2022","journal-title":"Oncogene"},{"key":"2026101503093693800_bib67","doi-asserted-by":"publisher","first-page":"167315","DOI":"10.1016\/j.scitotenv.2023.167315","article-title":"Mitochondrial DNA release mediated by TFAM deficiency promotes copper-induced mitochondrial innate immune response via cGAS-STING signalling in chicken hepatocytes","volume":"905","author":"Li","year":"2023","journal-title":"Sci Total Environ"},{"key":"2026101503093693800_bib68","doi-asserted-by":"publisher","first-page":"155330","DOI":"10.1016\/j.prp.2024.155330","article-title":"Release of damaged mitochondrial DNA: a novel factor in stimulating inflammatory response","volume":"258","author":"Li","year":"2024","journal-title":"Pathol Res Pract"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-4738\/3813931\/can-25-4738.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-4738\/3824725\/can-25-4738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/20\/5287\/3837126\/can-25-4738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/20\/5287\/3837126\/can-25-4738.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:09:49Z","timestamp":1792048189000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/20\/5287\/788697\/Single-Cell-Analysis-of-Residual-Esophageal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":68,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,7,20]]},"published-print":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-25-4738","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.34520338","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520347","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520359","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520335","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520365","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520344","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520341","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520350","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8775292","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}